FindTrial
Sign In

ROLE OF FLUORECENCE STAINING IN DETECTING LEPRAE BACILLI IN LEPROSY

IMMUNOFLUORESCENCE MICROSCOPY STAINING OF SLIT SKIN SMEAR FOR DETECTION OF MYCOBACTERIUM LEPRAE

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/07/055060
Enrollment
63
Registered
2023-07-11
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A309- Leprosy, unspecified

Interventions

Control Intervention1: NIL: NIL

Sponsors

Dr Sujata Maurya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Cases clinically diagnosed as leprosy

Exclusion criteria

Exclusion criteria: Patients not willing to give written informed consent with or without photography Hypersensitivity to local anaesthesia

Design outcomes

Primary

MeasureTime frame
PRESENCE OF LEPRAE BACILLI IN SLIT SKIN SMEAR BY AURAMINE-O STAININGTimepoint: OVER 1 YEAR—

Secondary

MeasureTime frame
POSITIVE OR NEGATIVE BACTERIOLOGICAL INDEXTimepoint: BASELINE—

Countries

India

Contacts

Public ContactDR SUJATA MAURYA

MBBS, MD (DERMATOLOGY), SRMS IMS, BAREILLY

drmadhurkant.srmsims@gmail.com9808158474

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026